Prevalence of persistent SARS-CoV-2 in a large community surveillance study

Persistent SARS-CoV-2 infections may act as viral reservoirs that could seed future outbreaks 1–5, give rise to highly divergent lineages 6–8, and contribute to cases with post-acute COVID-19 sequelae (Long Covid) 9,10. However, the population prevalence of persistent infections, their viral load ki...

Full description

Bibliographic Details
Main Authors: Ghafari, M, Hall, M, Golubchik, T, Ayoubkhani, D, House, T, Macintyre-Cockett, G, Fryer, HR, Thomson, L, Nurtay, A, Kemp, SA, Ferretti, L, Buck, D, Green, A, Trebes, A, Piazza, P, Lonie, L, Studley, R, Rourke, E, Smith, D, Bashton, M, Nelson, A, Crown, M, McCann, C, Young, GR, Nunes dos Santos, RA, Richards, Z, Tariq, A, Cahuantzi, R, Barrett, J, Fraser, C, Bonsall, D, Walker, AS, Lythgoe, K
Other Authors: Wellcome Sanger Institute COVID-19 Surveillance Team
Format: Journal article
Language:English
Published: Springer Nature 2024
_version_ 1797113155994779648
author Ghafari, M
Hall, M
Golubchik, T
Ayoubkhani, D
House, T
Macintyre-Cockett, G
Fryer, HR
Thomson, L
Nurtay, A
Kemp, SA
Ferretti, L
Buck, D
Green, A
Trebes, A
Piazza, P
Lonie, L
Studley, R
Rourke, E
Smith, D
Bashton, M
Nelson, A
Crown, M
McCann, C
Young, GR
Nunes dos Santos, RA
Richards, Z
Tariq, A
Cahuantzi, R
Barrett, J
Fraser, C
Bonsall, D
Walker, AS
Lythgoe, K
author2 Wellcome Sanger Institute COVID-19 Surveillance Team
author_facet Wellcome Sanger Institute COVID-19 Surveillance Team
Ghafari, M
Hall, M
Golubchik, T
Ayoubkhani, D
House, T
Macintyre-Cockett, G
Fryer, HR
Thomson, L
Nurtay, A
Kemp, SA
Ferretti, L
Buck, D
Green, A
Trebes, A
Piazza, P
Lonie, L
Studley, R
Rourke, E
Smith, D
Bashton, M
Nelson, A
Crown, M
McCann, C
Young, GR
Nunes dos Santos, RA
Richards, Z
Tariq, A
Cahuantzi, R
Barrett, J
Fraser, C
Bonsall, D
Walker, AS
Lythgoe, K
author_sort Ghafari, M
collection OXFORD
description Persistent SARS-CoV-2 infections may act as viral reservoirs that could seed future outbreaks 1–5, give rise to highly divergent lineages 6–8, and contribute to cases with post-acute COVID-19 sequelae (Long Covid) 9,10. However, the population prevalence of persistent infections, their viral load kinetics, and evolutionary dynamics over the course of infections remain largely unknown. Using viral sequence data collected as part of a national infection survey, we identified 381 individuals with SARS-CoV-2 RNA at high titre persisting for at least 30 days, of which 54 had viral RNA persisting at least 60 days. We refer to these as ‘persistent infections’ since available evidence suggests they represent ongoing viral replication, although the persistence of non-replicating RNA cannot be ruled out in all. Persistently infected individuals had more than 50% higher odds of self-reporting Long Covid compared to non-persistently infected individuals. We estimate that 0.1- 0.5% of infections may become persistent with typically rebounding high viral loads and last for at least 60 days. In some individuals, we identified many viral amino acid substitutions, indicating periods of strong positive selection, while others had no consensus change in the sequences for prolonged periods, consistent with weak selection. Substitutions included mutations that are lineage-defining for SARS-CoV-2 variants, at target sites for monoclonal antibodies, and/or commonly found in immunocompromised patients 11–14. This work has significant implications for understanding and characterising SARS-CoV-2 infection, epidemiology, and evolution.
first_indexed 2024-03-07T08:18:55Z
format Journal article
id oxford-uuid:9058a2db-4a64-480b-99f5-dfc8bd8edd2e
institution University of Oxford
language English
last_indexed 2024-04-23T08:24:20Z
publishDate 2024
publisher Springer Nature
record_format dspace
spelling oxford-uuid:9058a2db-4a64-480b-99f5-dfc8bd8edd2e2024-04-10T09:47:04ZPrevalence of persistent SARS-CoV-2 in a large community surveillance studyJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:9058a2db-4a64-480b-99f5-dfc8bd8edd2eEnglishSymplectic ElementsSpringer Nature2024Ghafari, MHall, MGolubchik, TAyoubkhani, DHouse, TMacintyre-Cockett, GFryer, HRThomson, LNurtay, AKemp, SAFerretti, LBuck, DGreen, ATrebes, APiazza, PLonie, LStudley, RRourke, ESmith, DBashton, MNelson, ACrown, MMcCann, CYoung, GRNunes dos Santos, RARichards, ZTariq, ACahuantzi, RBarrett, JFraser, CBonsall, DWalker, ASLythgoe, KWellcome Sanger Institute COVID-19 Surveillance TeamCOVID-19 Infection Survey GroupThe COVID-19 Genomics UK (COG-UK) ConsortiumPersistent SARS-CoV-2 infections may act as viral reservoirs that could seed future outbreaks 1–5, give rise to highly divergent lineages 6–8, and contribute to cases with post-acute COVID-19 sequelae (Long Covid) 9,10. However, the population prevalence of persistent infections, their viral load kinetics, and evolutionary dynamics over the course of infections remain largely unknown. Using viral sequence data collected as part of a national infection survey, we identified 381 individuals with SARS-CoV-2 RNA at high titre persisting for at least 30 days, of which 54 had viral RNA persisting at least 60 days. We refer to these as ‘persistent infections’ since available evidence suggests they represent ongoing viral replication, although the persistence of non-replicating RNA cannot be ruled out in all. Persistently infected individuals had more than 50% higher odds of self-reporting Long Covid compared to non-persistently infected individuals. We estimate that 0.1- 0.5% of infections may become persistent with typically rebounding high viral loads and last for at least 60 days. In some individuals, we identified many viral amino acid substitutions, indicating periods of strong positive selection, while others had no consensus change in the sequences for prolonged periods, consistent with weak selection. Substitutions included mutations that are lineage-defining for SARS-CoV-2 variants, at target sites for monoclonal antibodies, and/or commonly found in immunocompromised patients 11–14. This work has significant implications for understanding and characterising SARS-CoV-2 infection, epidemiology, and evolution.
spellingShingle Ghafari, M
Hall, M
Golubchik, T
Ayoubkhani, D
House, T
Macintyre-Cockett, G
Fryer, HR
Thomson, L
Nurtay, A
Kemp, SA
Ferretti, L
Buck, D
Green, A
Trebes, A
Piazza, P
Lonie, L
Studley, R
Rourke, E
Smith, D
Bashton, M
Nelson, A
Crown, M
McCann, C
Young, GR
Nunes dos Santos, RA
Richards, Z
Tariq, A
Cahuantzi, R
Barrett, J
Fraser, C
Bonsall, D
Walker, AS
Lythgoe, K
Prevalence of persistent SARS-CoV-2 in a large community surveillance study
title Prevalence of persistent SARS-CoV-2 in a large community surveillance study
title_full Prevalence of persistent SARS-CoV-2 in a large community surveillance study
title_fullStr Prevalence of persistent SARS-CoV-2 in a large community surveillance study
title_full_unstemmed Prevalence of persistent SARS-CoV-2 in a large community surveillance study
title_short Prevalence of persistent SARS-CoV-2 in a large community surveillance study
title_sort prevalence of persistent sars cov 2 in a large community surveillance study
work_keys_str_mv AT ghafarim prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy
AT hallm prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy
AT golubchikt prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy
AT ayoubkhanid prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy
AT houset prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy
AT macintyrecockettg prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy
AT fryerhr prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy
AT thomsonl prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy
AT nurtaya prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy
AT kempsa prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy
AT ferrettil prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy
AT buckd prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy
AT greena prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy
AT trebesa prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy
AT piazzap prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy
AT loniel prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy
AT studleyr prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy
AT rourkee prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy
AT smithd prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy
AT bashtonm prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy
AT nelsona prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy
AT crownm prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy
AT mccannc prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy
AT younggr prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy
AT nunesdossantosra prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy
AT richardsz prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy
AT tariqa prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy
AT cahuantzir prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy
AT barrettj prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy
AT fraserc prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy
AT bonsalld prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy
AT walkeras prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy
AT lythgoek prevalenceofpersistentsarscov2inalargecommunitysurveillancestudy